Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Systematic Review
  • Published:

Effect of magnesium supplementation on blood pressure: a meta-analysis

Abstract

To date, there has been inconclusive evidence regarding the effect of magnesium supplements on blood pressure (BP). This meta-analysis was conducted to assess the effect of magnesium supplementation on BP and to establish the characteristics of trials showing the largest effect size. Primary outcome measures were systolic blood pressure (SBP) and diastolic blood pressure (DBP) at the end of the follow-up period. One hundred and forty-one papers were identified, of which 22 trials with 23 sets of data (n=1173), with 3 to 24 weeks of follow-up met the inclusion criteria, with a supplemented elemental magnesium range of 120–973 mg (mean dose 410 mg). 95% confidence intervals (CI) were calculated using DerSimonian and Laird's random-effects model, with effect size calculated using Hedges G. Combining all data, an overall effect of 0.36 and 0.32 for DBP and SBP, respectively, was observed (95% CI 0.27–0.44 for DBP and 0.23–0.41 for SBP), with a greater effect being seen for the intervention in crossover trials (DBP 0.47, SBP 0.51). Effect size increased in line with increased dosage. Although not all individual trials showed significance in BP reduction, combining all trials did show a decrease in SBP of 3–4 mm Hg and DBP of 2–3 mm Hg, which further increased with crossover designed trials and intake >370 mg/day. To conclude, magnesium supplementation appears to achieve a small but clinically significant reduction in BP, an effect worthy of future prospective large randomised trials using solid methodology.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Lawes CMM, Vander Hoorn S, Rodgers A . The International Society of Hypertension, global burden of blood-pressure-related disease. Lancet 2008; 371, 1513–1518.

    Article  Google Scholar 

  2. Bo S, Pisu E . Role of magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr Opin Lipidol 2008; 19, 50–56.

    Article  CAS  Google Scholar 

  3. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes and carotid arterial wall thickness: the ARIC study. J Clin Epidemiol 1995; 48, 927–940.

    Article  CAS  Google Scholar 

  4. Kawano Y, Matsuoka H, Takishita S, Omae T . Effects of magnesium supplementation in hypertensive patients, assessment by office, home, and ambulatory blood pressures. Hypertension 1998; 32, 260–265.

    Article  CAS  Google Scholar 

  5. Altura BM . Importance of Mg in physiology and medicine and the need for ion selective electrodes. Scand J Clin Lab Invest 1994; 54 (Suppl 217), 5–9.

    Article  CAS  Google Scholar 

  6. Department of Health. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Report of the Panel on Dietary Reference Values, Committee on Medical Aspects of Food and Nutrition Policy. HMSO: London, 1991.

  7. Bohl CH, Volpe SL . Magnesium and exercise. Crit Rev Food Sci Nutr 2002; 42, 533–563.

    Article  CAS  Google Scholar 

  8. Choudhury A, Lip GYH . Exercise and hypertension. J Hum Hypertens 2005; 19, 585–587.

    Article  CAS  Google Scholar 

  9. Burgess E, Lewanczuk R, Bolli P, Chockalingam A, Cutler H, Taylor G et al. Recommendations on potassium, magnesium and calcium. Canad Med Assoc J 1999; 160 (Suppl 9), S35–S45.

    CAS  Google Scholar 

  10. Dickinson HO, Nicolson D, Campbell F, Cook JF, Beyer FR, Ford GA et al. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev 2006; (19), CD004640.

  11. Jee SH, Edgar R, Miller III, Guallar E, Singh VK, Appel LJ et al. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 2002; 15, 691–696.

    Article  CAS  Google Scholar 

  12. Hedges LV, Olkin I . Statistical Methods for Meta-Analysis. Academic Press: Orlando, 1985.

    Google Scholar 

  13. Morris SB . Distribution of the standardized mean change effect size for meta-analysis on repeated measures. Br J Math Stat Psychol 2000; 53 (Part 1), 17–29.

    Article  Google Scholar 

  14. DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials 1986; 7, 177–187.

    Article  CAS  Google Scholar 

  15. Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G, Salinas-Martinez AM, Montes-Villarreal J, Trevino-Ortiz JH et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diab Metab 2004; 30, 253–258.

    Article  CAS  Google Scholar 

  16. Henderson DG, Schierup J, Schodt T . Effect of magnesium supplementation on blood pressure and electrolyte concentrations in hypertensive patients receiving long term diuretic treatment. Br Med J 1986; 293, 664–665.

    Article  CAS  Google Scholar 

  17. Doyle L, Flynn A, Cashman K . The effect of magnesium supplementation on biochemical markers of bone metabolism or blood pressure in healthy young adult females. Eur J Clin Nutr 1999; 53, 255–261.

    Article  CAS  Google Scholar 

  18. Sacks FM, Willett WC, Smith A, Brown LE, Rosner B, Moore TJ . Effect on blood pressure of potassium, calcium and magnesium in women with low habitual intake. Hypertension 1998; 31, 131–138.

    Article  CAS  Google Scholar 

  19. Witteman JCM, Grobbee DE, Derkx FHM, Bouillon R, de Bruijn AM, Hofman A . Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr 1994; 60, 129–135.

    Article  CAS  Google Scholar 

  20. Guerrero-Romero F, Rodriguez-Moran M . The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J Hum Hypertens 2009; 23, 245–251.

    Article  CAS  Google Scholar 

  21. Rodriguez-Moran M, Guerrero-Romero F . Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. Diabetes Care 2003; 26, 1147–1152.

    Article  CAS  Google Scholar 

  22. Purvis JR, Cummings DM, Landsman P, Carroll R, Barakat H, Bray J et al. Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin-dependent diabetics. Arch Family Med 1994; 3, 503–508.

    Article  CAS  Google Scholar 

  23. Hattori K, Saito K, Sano H, Fukuzaki H . Intracellular magnesium deficiency and effect of oral magnesium on blood pressure and red cell sodium transport in diuretic-treated hypertensive patients. Jpn Circ J 1988; 52, 1249–1256.

    Article  CAS  Google Scholar 

  24. Borrello G, Mastroroberto P, Curcio F, Chello M, Zofrea S, Mazza ML . The effects of magnesium oxide on mild essential hypertension and quality of life. Curr Ther Res 1996; 57, 767–774.

    Article  CAS  Google Scholar 

  25. Zemel PC, Zemel MB, Urberg M, Douglas FL, Geiser R, Sowers JR . Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension. Am J Clin Nutr 1990; 51, 665–669.

    Article  CAS  Google Scholar 

  26. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288, 2981–2997.

    Article  Google Scholar 

  27. Mizushima S, Cappuccio FP, Nichols R, Elliott P . Dietary magnesium intake and blood pressure: a qualitative overview of the observational studies. J Hum Hypertens 1998; 12, 447–453.

    Article  CAS  Google Scholar 

  28. Lee S, Park HK, Son SP, Lee CW, Kim IJ, Kim HJ . Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults. Nutr Metab Cardiovasc Dis 2009; 19, 781–788.

    Article  CAS  Google Scholar 

  29. Lind L, Lithell H, Pollare T, Ljunghall S . Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. Am J Hypertens 1991; 4, 674–679.

    Article  CAS  Google Scholar 

  30. Ferrara LA, Iannuzzi R, Castaldo A, Iannuzzi A, Russo AD, Mancini M . Long-term magnesium supplementation in essential hypertension. Cardiology 1992; 81, 25–33.

    Article  CAS  Google Scholar 

  31. Wirell MP, Wester PO, Stegmayr BG . Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: a double-blind cross-over study. J Intern Med 1994; 236, 189–195.

    Article  CAS  Google Scholar 

  32. Plum-Wirell M, Stegmay BG, Weste PO . Nutritional magnesium supplementation does not change blood pressure nor serum or muscle potassium and magnesium in untreated hypertension. A double-blind crossover study. Magn Res 1994; 7, 277–283.

    CAS  Google Scholar 

  33. Itoh K, Kawasaki T, Nakamur M . The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr 1997; 78, 737–750.

    Article  CAS  Google Scholar 

  34. Sanjuliani AF, Fagundes VGA, Francischetti EA . Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. Intern J Cardiol 1996; 56, 177–183.

    Article  CAS  Google Scholar 

  35. Paolisso G, Di Maro G, Cozzolino D, Salvatore T, D’Amore A, Lama D et al. Chronic magnesium administration enhances oxidative glucose metabolism in thiazide treated hypertensive patients. Am J Hypertens 1992; 5, 681–686.

    Article  CAS  Google Scholar 

  36. Cappuccio FP, Markandu ND, Beynon GW, Shore AC, Sampson B, MacGregor GA . Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J 1985; 291, 235–238.

    Article  CAS  Google Scholar 

  37. Widman L, Wester PO, Stegmayr BK, Wirell M . The dose-dependent reduction in blood pressure through administration of magnesium. Am J Hypertens 1993; 6, 41–45.

    Article  CAS  Google Scholar 

  38. Nielsen FH, Lukaski HC . Update on the relationship between magnesium and exercise. Magn Res 2006; 19, 180–189.

    CAS  Google Scholar 

Download references

Acknowledgements

The authors are grateful to Dr David Wellsted and the Centre for Lifespan and Chronic Illness Research (CLiCIR), University of Hertfordshire, for their invaluable advice and support on this project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L Kass.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kass, L., Weekes, J. & Carpenter, L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 66, 411–418 (2012). https://doi.org/10.1038/ejcn.2012.4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2012.4

Keywords

This article is cited by

Search

Quick links